Home » Topics » Regulatory » Patents

Patents
RSS

RemeGen describes new angiogenesis inhibitors

July 8, 2020

Prelude Therapeutics discloses Mcl-1 inhibitors

July 8, 2020

Theravance Biopharma patents TGFR-1 inhibitors

July 8, 2020

Dana-Farber Cancer Institute presents new MAPK9 inhibitors

July 8, 2020

Researchers identify claudin 18.2-targeting antibodies

July 7, 2020

Sunshine Lake Pharma presents CD19-targeting antibodies

July 7, 2020

Japanese researchers report new immunosuppressants

July 7, 2020

SIAT patents anti-H7N9 fully human monoclonal antibody 2G3 for H7N9 viral infection

July 7, 2020

OncoSec Medical divulges expression vectors encoding nucleic acid sequences for cancer

July 7, 2020

Ideaya Biosciences discovers MAT2A inhibitors

July 6, 2020

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...